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To the Editor:
We read with great interest the American College of Chest Physicians’ guidelines for lung 
cancer screening1 and the excellent Point and Counterpoint editorials by Drs Wood and 
Mazzone2–5 in CHEST (June 2018) addressing the important issue of how to approach 
persons at high risk for lung cancer who don’t meet the guidelines’ core criteria for lung 
cancer screening. In his final rebuttal, Dr Mazzone5 states that the guidelines “...recommend 
that the cohort that does not meet our core eligibility criteria, but is at elevated risk for lung 
cancer based on risk calculators, should not be ‘routinely’ screened. We remark under this 
recommendation that although we do not recommend ‘routinely’ screening this cohort, we 
recognize that some individuals within this high-risk cohort will be healthy enough to 
consider screening.”
We agree that lung cancer screening should be considered for high-risk individuals, in whom 
the benefits of screening are likely to exceed harms, and urge practitioners to take 
occupational and environmental histories from their patients and consider associated 
exposures to carcinogens when deciding about whether to enter into shared decision-making 
about screening. Exposure to occupational and environmental carcinogens is a well-
established lung cancer risk factor, as noted in a recent update of the National
Comprehensive Cancer Network (NCCN) guidelines, of which Drs Wood and Mazzone are 
both authors.6 Consideration of exposure to occupational and environmental lung 
carcinogens is especially important because they can synergize with smoking history to 
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increase risk in a greater-than-additive fashion.7 Also, there is potential for benefit, as 
documented in a recent systematic review of lung cancer screening after asbestos exposure 
published in this journal.8
Unfortunately, exposures to most known occupational and environmental carcinogens are 
not considered by currently available risk calculators. In view of this, we support 
consideration of lung cancer screening in those who meet NCCN group 2 criteria, are aged 
50 or older with a ≥20 pack-year history of smoking tobacco, and with one additional risk 
factor (in this case, personal history of exposure to radon or occupational carcinogens).6 In 
the case of occupational carcinogens, a French workgroup has suggested 10 years of 
exposure as a pragmatic threshold for consideration of screening.7 We urge that all such 
screening be done within the context of comprehensive screening programs and that, in the 
United States, data be reported to the national lung cancer screening registry operated by the 
American College of Radiology.
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